SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
about
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@en
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@nl
type
label
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@en
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@nl
prefLabel
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@en
SGLT-2 Inhibitors and Cardiova ...... nhibitors With GLP-1 Agonists.
@nl
P2093
P2860
P356
P1476
SGLT-2 Inhibitors and Cardiova ...... Inhibitors With GLP-1 Agonists
@en
P2093
Alaaeldin Bashier
Elamin Abdelgadir
Fauzia Rashid
P2860
P304
P356
10.14740/JOCMR3467W
P577
2018-06-27T00:00:00Z